This biotechnology company is open for trading in the CSE under the trade name DRUG. Scientific researchers at this company focus on developing novel transformative cures for treating chronic pain, epilepsy, and neuropsychiatry disorders.
This biotechnology company is open for trading in the CSE under the trade name DRUG. Scientific researchers at this company focus on developing novel transformative cures for treating chronic pain, epilepsy, and neuropsychiatry disorders.